Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
7.40
-0.10 (-1.33%)
At close: Nov 7, 2025, 4:00 PM EST
7.35
-0.06 (-0.74%)
After-hours: Nov 7, 2025, 4:04 PM EST
Kazia Therapeutics Market Cap
Kazia Therapeutics has a market cap or net worth of $8.19 million as of November 7, 2025. Its market cap has decreased by -52.52% in one year.
Market Cap
8.19M
Enterprise Value
5.60M
1-Year Change
-52.52%
Ranking
Category
Stock Price
$7.40
Market Cap Chart
Since September 1, 1999, Kazia Therapeutics's market cap has decreased from $141.44M to $8.19M, a decrease of -94.21%. That is a compound annual growth rate of -10.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 8.19M | 6.30% |
| Dec 31, 2024 | 7.71M | -33.47% |
| Dec 29, 2023 | 11.59M | 15.31% |
| Dec 30, 2022 | 10.05M | -90.96% |
| Dec 31, 2021 | 111.18M | 11.75% |
| Dec 31, 2020 | 99.49M | 217.65% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 827.07B |
| Johnson & Johnson | 450.22B |
| AbbVie | 384.76B |
| UnitedHealth Group | 292.75B |
| AstraZeneca | 251.76B |
| Novartis AG | 240.29B |
| Abbott Laboratories | 216.75B |
| Thermo Fisher Scientific | 211.79B |